Company / Assets per Share
Matinas BioPharma Holdings, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.91
FY2024
5-year range
$0.12 / $2.91
FY2020-FY2024
Trend
+2417.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +2418% YoY in FY2024, a notable deviation from the 9-year average annual change of +266%.
Based on SEC 10-K filings.
2.91 in FY2024 with a 5-year CAGR of +52.3%.
Improved from $0.21 to $2.91 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +111.7%
- 5-Year CAGR
- +52.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, assets per share increased 2417.7% year-over-year.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.91 | +2417.7% |
| FY2023 | $0.12 | -44.2% |
| FY2022 | $0.21 | -32.4% |
| FY2021 | $0.31 | -29.5% |
| FY2020 | $0.43 | +22.5% |
| FY2019 | $0.36 | +66.3% |
| FY2018 | $0.21 | -13.9% |
| FY2017 | $0.25 | +44.5% |
| FY2016 | $0.17 | -34.1% |
| FY2015 | $0.26 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026